Structure Based Discovery of Clomifene as a Potent Inhibitor of Cancer-Associated Mutant IDH1

Oncotarget- United States

doi 10.18632/oncotarget.17464

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

Impact Journals, LLC

Related search

Discovery of a Potent PLK1-PBD Small-Molecule Inhibitor as an Anticancer Drug Candidate Through Structure-Based Design

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

Combination Treatment of an IDH1 Inhibitor With Chemotherapy in IDH1 Mutant Acute Myeloid Leukemia

Annals of Hematology
MedicineHematology
2020English

Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins

English

A Brain Penetrant Mutant IDH1 Inhibitor Provides in Vivo Survival Benefit

Scientific Reports
Multidisciplinary
2017Breton

“Nojirimycin” as a Potent Inhibitor of Glucosidase

Agricultural and Biological Chemistry
1970English

Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity

Structure
Structural BiologyMolecular Biology
2017English

Discovery of N-(2-Aminophenyl)-4-(Bis(2-Chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor

Frontiers in Pharmacology
Pharmacology
2019English

Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2010English

Discovery of 4-Aryl-2-Benzoyl-Imidazoles as Tubulin Polymerization Inhibitor With Potent Antiproliferative Properties

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy